In every issue, you’ll find the hottest topics of interest to our readers along with cutting-edge health information.
Also Available On:
Understanding Immigration and HIV
POZ writers and artists have thrived at the magical intersection of lived experience and boundless talent.
Consejos para comunicar
Our cover story explores how HIV intersects with immigration and affects everyone from asylum seekers to longtime immigrants.
Lambda Literary speaks with Emanuel Xavier about the club scene, HIV/AIDS and the reissue of his cult novel.
Updates on U=U, PrEP, harm reduction and more
A look at fall issues from the POZ archives
Here are some important dates in AIDS history.
Christine Soyong Harley, CEO of the U.S. Sexuality Information and Education Council, urges schools to address HIV.
Tony Taylor, a project manager at Building Healthy Online Communities, urges kindness.
Advocates respond to the reports that a father, who is living with HIV, was permanently separated from his daughters after entering the U.S.
A new analysis of the global START trial found that health outcomes were better for those starting treatment within six months.
The attachment inhibitor plus an optimized antiretroviral background regimen suppressed HIV in the majority of study participants.
Merck’s experimental HIV drug proves effective and well tolerated
Pharmacist-driven hep C treatment sees good cure rates
The Mosaico study will enroll gay and bisexual men and transgender people at significant risk for the virus.
The investigational, injectable, long-acting antiretroviral is a potential new option for those with multidrug resistance.
CRISPR gene editing eliminates HIV in mice
A high proportion of people with HIV suffer from anxiety, which is associated with lower rates of HIV treatment and adherence to treatment.
Oscar Lopez advocates for Latinos living with HIV.
Read the digital edition!